356 related articles for article (PubMed ID: 32331858)
1. Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness.
Leake PA; Akil O; Lang H
Hear Res; 2020 Sep; 394():107955. PubMed ID: 32331858
[TBL] [Abstract][Full Text] [Related]
2. The effect of deafness duration on neurotrophin gene therapy for spiral ganglion neuron protection.
Wise AK; Tu T; Atkinson PJ; Flynn BO; Sgro BE; Hume C; O'Leary SJ; Shepherd RK; Richardson RT
Hear Res; 2011 Aug; 278(1-2):69-76. PubMed ID: 21557994
[TBL] [Abstract][Full Text] [Related]
3. AAV-Mediated Neurotrophin Gene Therapy Promotes Improved Survival of Cochlear Spiral Ganglion Neurons in Neonatally Deafened Cats: Comparison of AAV2-hBDNF and AAV5-hGDNF.
Leake PA; Rebscher SJ; Dore' C; Akil O
J Assoc Res Otolaryngol; 2019 Aug; 20(4):341-361. PubMed ID: 31222416
[TBL] [Abstract][Full Text] [Related]
4. Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment.
Landry TG; Wise AK; Fallon JB; Shepherd RK
Hear Res; 2011 Dec; 282(1-2):303-13. PubMed ID: 21762764
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophin Gene Therapy in Deafened Ears with Cochlear Implants: Long-term Effects on Nerve Survival and Functional Measures.
Pfingst BE; Colesa DJ; Swiderski DL; Hughes AP; Strahl SB; Sinan M; Raphael Y
J Assoc Res Otolaryngol; 2017 Dec; 18(6):731-750. PubMed ID: 28776202
[TBL] [Abstract][Full Text] [Related]
6. Development of a cell-based treatment for long-term neurotrophin expression and spiral ganglion neuron survival.
Zanin MP; Hellström M; Shepherd RK; Harvey AR; Gillespie LN
Neuroscience; 2014 Sep; 277():690-9. PubMed ID: 25088914
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of AAV.BDNF and AAV.Ntf3 in the deafened adult guinea pig ear.
Budenz CL; Wong HT; Swiderski DL; Shibata SB; Pfingst BE; Raphael Y
Sci Rep; 2015 Mar; 5():8619. PubMed ID: 25726967
[TBL] [Abstract][Full Text] [Related]
8. Temporary Neurotrophin Treatment Prevents Deafness-Induced Auditory Nerve Degeneration and Preserves Function.
Ramekers D; Versnel H; Strahl SB; Klis SF; Grolman W
J Neurosci; 2015 Sep; 35(36):12331-45. PubMed ID: 26354903
[TBL] [Abstract][Full Text] [Related]
9. Effects of brain-derived neurotrophic factor (BDNF) and electrical stimulation on survival and function of cochlear spiral ganglion neurons in deafened, developing cats.
Leake PA; Stakhovskaya O; Hetherington A; Rebscher SJ; Bonham B
J Assoc Res Otolaryngol; 2013 Apr; 14(2):187-211. PubMed ID: 23392612
[TBL] [Abstract][Full Text] [Related]
10. Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons.
Rejali D; Lee VA; Abrashkin KA; Humayun N; Swiderski DL; Raphael Y
Hear Res; 2007 Jun; 228(1-2):180-7. PubMed ID: 17416474
[TBL] [Abstract][Full Text] [Related]
11. Chronic neurotrophin delivery promotes ectopic neurite growth from the spiral ganglion of deafened cochleae without compromising the spatial selectivity of cochlear implants.
Landry TG; Fallon JB; Wise AK; Shepherd RK
J Comp Neurol; 2013 Aug; 521(12):2818-32. PubMed ID: 23436344
[TBL] [Abstract][Full Text] [Related]
12. Effects of localized neurotrophin gene expression on spiral ganglion neuron resprouting in the deafened cochlea.
Wise AK; Hume CR; Flynn BO; Jeelall YS; Suhr CL; Sgro BE; O'Leary SJ; Shepherd RK; Richardson RT
Mol Ther; 2010 Jun; 18(6):1111-22. PubMed ID: 20216530
[TBL] [Abstract][Full Text] [Related]
13. Schwann cells genetically modified to express neurotrophins promote spiral ganglion neuron survival in vitro.
Pettingill LN; Minter RL; Shepherd RK
Neuroscience; 2008 Mar; 152(3):821-8. PubMed ID: 18304740
[TBL] [Abstract][Full Text] [Related]
14. Neurotrophin gene therapy for sustained neural preservation after deafness.
Atkinson PJ; Wise AK; Flynn BO; Nayagam BA; Hume CR; O'Leary SJ; Shepherd RK; Richardson RT
PLoS One; 2012; 7(12):e52338. PubMed ID: 23284995
[TBL] [Abstract][Full Text] [Related]
15. Postnatal expression of neurotrophic factors accessible to spiral ganglion neurons in the auditory system of adult hearing and deafened rats.
Bailey EM; Green SH
J Neurosci; 2014 Sep; 34(39):13110-26. PubMed ID: 25253857
[TBL] [Abstract][Full Text] [Related]
16. Virally Mediated Overexpression of Glial-Derived Neurotrophic Factor Elicits Age- and Dose-Dependent Neuronal Toxicity and Hearing Loss.
Akil O; Blits B; Lustig LR; Leake PA
Hum Gene Ther; 2019 Jan; 30(1):88-105. PubMed ID: 30183384
[TBL] [Abstract][Full Text] [Related]
17. Brain-derived neurotrophic factor modulates auditory function in the hearing cochlea.
Sly DJ; Hampson AJ; Minter RL; Heffer LF; Li J; Millard RE; Winata L; Niasari A; O'Leary SJ
J Assoc Res Otolaryngol; 2012 Feb; 13(1):1-16. PubMed ID: 22086147
[TBL] [Abstract][Full Text] [Related]
18. Exogenous BDNF rescues rat spiral ganglion neurons in vivo.
McGuinness SL; Shepherd RK
Otol Neurotol; 2005 Sep; 26(5):1064-72. PubMed ID: 16151360
[TBL] [Abstract][Full Text] [Related]
19. Expression of Brain-Derived Neurotrophic Factor in Human Spiral Ganglia Neurons after Cochlear Implantation.
Wong EC; Lopez IA; Ishiyama A; Ishiyama G
Otol Neurotol; 2024 Mar; 45(3):326-333. PubMed ID: 38238917
[TBL] [Abstract][Full Text] [Related]
20. Connexin 26 null mice exhibit spiral ganglion degeneration that can be blocked by BDNF gene therapy.
Takada Y; Beyer LA; Swiderski DL; O'Neal AL; Prieskorn DM; Shivatzki S; Avraham KB; Raphael Y
Hear Res; 2014 Mar; 309():124-35. PubMed ID: 24333301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
